News
March 18, 2024
7th Theranostics World Congress
We are thrilled to announce our participation in the upcoming 7th Theranostics World Congress, where our esteemed experts will be sharing groundbreaking insights and innovations in the field of theranostics.
Dr. Andreas Jensen, CEO and co-founder of TetraKit Technologies, will be giving a talk on March 24th, highlighting our platform’s inventive application in next-generation theranostics.
Dr. Matthias Herth, our CSO, will take the stage on March 23rd to discuss ²¹¹At-PSMA for alpha-RLT (Radioligand Therapy) of prostate cancer, showcasing TetraKit’s advancements in personalized cancer treatment.
Dr. Marcel Martin, our Senior Radiochemistry expert, will present on March 24th, focusing on new dimeric FAPi radioligands and their optimized properties for radioligand therapy to improve therapeutic efficacy.
Join us at our booth during the conference for engaging discussions, valuable insights, and a closer look at our latest innovations. Your presence will add immense value to these special occasions as we collectively explore the future of theranostics and healthcare innovation.
Don’t miss this opportunity to connect, learn, and collaborate! Visit the 7th Theranostics World Congress website and join our presentations. See you there! 🚀 #TetraKitTechnologies #TheranosticsWorldCongress #HealthcareInnovation
